Experience you can feel – Our company for quality implants

POLYTECH Health & Aesthetics is one of the world’s leading manufacturers of silicone implants. Our success is directly linked with our innovative spirit, commitment to quality and more than 30 years of experience.

Established in 1986 in Dieburg, Germany, we continue to expand our range of services and constantly develop our products portfolio. Today reconstructive and aesthetic plastic surgeons from all over the world rely on our implants to perfectly replicate soft tissue in the human body, from breasts to calves. 

Our mission has always been to develop tailored solutions for the most varied requirements. Every person is unique, has different wishes and a very personal ideal of beauty. Our implants reflect that: In the field of breast implants alone, we offer more than 2,000 variants. All of them developed to meet the highest safety standards.

ContactMade in Germany

POLYTECH implants: The pursuit of quality

From day one, our philosophy has been to strive for perfection. In 1995, we were the first European manufacturer of breast implants to receive approval to bear the CE mark – three years before it became a mandatory EU requirement for all providers. And when the European Union placed breast implants in the highest safety category (Class III) for medical devices in 2003, we had already integrated these specifications into our processes. 

In order to guarantee only the best conditions, we decided in 2008 to relocate our entire manufacturing process to Germany. Since then, all POLYTECH implants have been developed on site in Dieburg and manufactured under clean room conditions. In that, we remain the only manufacturer of silicone implants which produces exclusively in Germany.

ContactOur history

Mit starken Partnern

With strong partners in the future

An essential part of our success lies in the close cooperation with our partners and investors. We keep an open dialogue with partners, surgeons and distributors in order to continuously develop our products and to enable us to implement cutting-edge technology at an early stage. 

We are constantly investing in our facilities and in research. In order to facilitate this growth, there was a change of ownership to Deutsche Beteiligungs AG (DBAG) in 2016: DBAG acquired a majority stake in POLYTECH within the framework of a management buyout. 

In 2017, we were able to open new production facilities to meet the increasing demand for our implants. 

Our Management

Our international activities

At present, POLYTECH operates in more than 75 countries and has over 250 employees. We all have one common goal: To develop the highest-quality, most advanced and safest implants, designed to meet the needs of both patients and surgeons.